These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bone marrow cells in X-linked agammaglobulinemia express pre-B-specific genes (lambda-like and V pre-B) and present immunoglobulin V-D-J gene usage strongly biased to a fetal-like repertoire. Milili M, Le Deist F, de Saint-Basile G, Fischer A, Fougereau M, Schiff C. J Clin Invest; 1993 Apr; 91(4):1616-29. PubMed ID: 8473505 [Abstract] [Full Text] [Related]
4. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages. de Weers M, Verschuren MC, Kraakman ME, Mensink RG, Schuurman RK, van Dongen JJ, Hendriks RW. Eur J Immunol; 1993 Dec; 23(12):3109-14. PubMed ID: 8258324 [Abstract] [Full Text] [Related]
5. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. Smith CI, Baskin B, Humire-Greiff P, Zhou JN, Olsson PG, Maniar HS, Kjellén P, Lambris JD, Christensson B, Hammarström L. J Immunol; 1994 Jan 15; 152(2):557-65. PubMed ID: 8283037 [Abstract] [Full Text] [Related]
6. Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia. Schuster V, Seidenspinner S, Kreth HW. Am J Med Genet; 1996 May 03; 63(1):318-22. PubMed ID: 8723128 [Abstract] [Full Text] [Related]
8. Characterization of germline mutations of the gene encoding Bruton's tyrosine kinase in families with X-linked agammaglobulinemia. Hagemann TL, Rosen FS, Kwan SP. Hum Mutat; 1995 May 03; 5(4):296-302. PubMed ID: 7627183 [Abstract] [Full Text] [Related]
9. Evidence for failure of V(D)J recombination in bone marrow pre-B cells from X-linked agammaglobulinemia. Schwaber J. J Clin Invest; 1992 Jun 03; 89(6):2053-9. PubMed ID: 1602011 [Abstract] [Full Text] [Related]
10. Diversity of immunoglobulin heavy chain gene segment rearrangement in B lymphoblastoid cell lines from X-linked agammaglobulinemia patients. Timmers E, Kenter M, Thompson A, Kraakman ME, Berman JE, Alt FW, Schuurman RK. Eur J Immunol; 1991 Oct 03; 21(10):2355-63. PubMed ID: 1915549 [Abstract] [Full Text] [Related]
11. Brief report: a point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia. Saffran DC, Parolini O, Fitch-Hilgenberg ME, Rawlings DJ, Afar DE, Witte ON, Conley ME. N Engl J Med; 1994 May 26; 330(21):1488-91. PubMed ID: 8164701 [No Abstract] [Full Text] [Related]
13. Early arrest in B cell development in transgenic mice that express the E41K Bruton's tyrosine kinase mutant under the control of the CD19 promoter region. Maas A, Dingjan GM, Grosveld F, Hendriks RW. J Immunol; 1999 Jun 01; 162(11):6526-33. PubMed ID: 10352268 [Abstract] [Full Text] [Related]
15. Mutation pattern in the Bruton's tyrosine kinase gene in 26 unrelated patients with X-linked agammaglobulinemia. Vorechovský I, Luo L, Hertz JM, Frøland SS, Klemola T, Fiorini M, Quinti I, Paganelli R, Ozsahin H, Hammarström L, Webster AD, Smith CI. Hum Mutat; 1997 Jun 01; 9(5):418-25. PubMed ID: 9143921 [Abstract] [Full Text] [Related]
18. Analysis of immunoglobulin gamma heavy chain expression in synovial tissue of a patient with rheumatoid arthritis. Bridges SL, Lee SK, Koopman WJ, Schroeder HW. Arthritis Rheum; 1993 May 01; 36(5):631-41. PubMed ID: 8489540 [Abstract] [Full Text] [Related]